Future studies are warranted to further explore the role of the SALL2–AXIN2 axis in response to standard chemotherapeutic agents such as 5-fluorouracil (5-FU) and to validate the clinical utility of SALL2 as a prognostic and predictive biomarker in CRC. Here, AXIN2 is linked to colorectal carcinoma.